New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2014
07:26 EDTLCILannett shares should be bought on weakness, says Oppenheimer
After Lannett reduced its Q4 guidance but provided higher than expected FY15 revenue guidance based on price increases it has implemented, Oppenheimer believes that investors should be pleased with the overall guidance. The firm keeps a $49 price target and Outperform rating on the stock.
News For LCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
10:28 EDTLCISenate Health, Education, Labor & Pensions Committee to hold a hearing
The Subcommittee on Primary Health and Aging holds a hearing entitled, "Why Are Some Generic Drugs Skyrocketing In Price?" with President & CEO Vigodman of Teva Pharmaceutical and President & CEO Bedrosian of Lannett Company on November 20 at 1 pm. Webcast Link
November 17, 2014
16:56 EDTLCILannett announces retirement of Chief Compliance Officer Ernest Sabo
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use